1. Home
  2. ALLK vs YSXT Comparison

ALLK vs YSXT Comparison

Compare ALLK & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • YSXT
  • Stock Information
  • Founded
  • ALLK 2012
  • YSXT 2011
  • Country
  • ALLK United States
  • YSXT China
  • Employees
  • ALLK N/A
  • YSXT N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • ALLK Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • ALLK Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • ALLK 101.0M
  • YSXT 87.9M
  • IPO Year
  • ALLK 2018
  • YSXT 2024
  • Fundamental
  • Price
  • ALLK $0.86
  • YSXT $4.66
  • Analyst Decision
  • ALLK Hold
  • YSXT
  • Analyst Count
  • ALLK 4
  • YSXT 0
  • Target Price
  • ALLK $1.67
  • YSXT N/A
  • AVG Volume (30 Days)
  • ALLK 827.7K
  • YSXT 235.9K
  • Earning Date
  • ALLK 03-13-2025
  • YSXT 01-01-0001
  • Dividend Yield
  • ALLK N/A
  • YSXT N/A
  • EPS Growth
  • ALLK N/A
  • YSXT N/A
  • EPS
  • ALLK N/A
  • YSXT 0.21
  • Revenue
  • ALLK N/A
  • YSXT $58,546,729.00
  • Revenue This Year
  • ALLK N/A
  • YSXT N/A
  • Revenue Next Year
  • ALLK N/A
  • YSXT N/A
  • P/E Ratio
  • ALLK N/A
  • YSXT $22.45
  • Revenue Growth
  • ALLK N/A
  • YSXT 18.92
  • 52 Week Low
  • ALLK $0.54
  • YSXT $2.54
  • 52 Week High
  • ALLK $1.69
  • YSXT $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 35.16
  • YSXT N/A
  • Support Level
  • ALLK $0.81
  • YSXT N/A
  • Resistance Level
  • ALLK $1.00
  • YSXT N/A
  • Average True Range (ATR)
  • ALLK 0.13
  • YSXT 0.00
  • MACD
  • ALLK -0.03
  • YSXT 0.00
  • Stochastic Oscillator
  • ALLK 8.43
  • YSXT 0.00

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: